Objective Inflammation and repair responses may be involved in atherosclerosis in rheumatoid arthritis (RA), although ...

An advisory committee will meet next week to review the information and make recommendations for the upcoming fall season. Charlie Kirk shooting suspect Tyler Robinson arrested, widow vows to fight ...

DUBLIN, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced that new data ...

The INFORM real-world evidence study shows impact of semaglutide on reducing ‘food noise’, and the STEP UP clinical trial highlights semaglutide’s effect on control of eating and body composition ...

BOSTON - Astria Therapeutics, Inc. (NASDAQ:ATXS) will present initial data from the Phase 1a trial of its investigational drug STAR-0310 at the European Academy of Dermatology & Venereology (EADV) ...

(Bloomberg) -- A popular Chinese financial data provider has halted releasing figures tracking local bond flows, according to some of the firm’s clients, as a rally in the country’s stock market fuels ...

SAN DIEGO - Neurocrine Biosciences, Inc. (NASDAQ:NBIX), a biopharmaceutical company with a market capitalization of $13.92 billion and impressive revenue growth of 18.42% over the last twelve months, ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Nucana ( (NCNA)) just unveiled an ...

Presentation to highlight preclinical pharmacokinetic and safety data supporting once-daily usage of Corsair’s TRX-248 Transdermal System, now in a Phase 1 clinical study Corsair Pharma, Inc., a ...

Poster presentation will feature new data for SYMPAZAN, the only FDA-approved oral film formulation of clobazam for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients ...

AC-201 is a novel, highly selective and potent oral small-molecule inhibitor of TYK2/JAK1 that binds to the pseudo kinase domain (JH2) of TYK2/JAK1, with minimal effect on the JAK2/JAK2 signaling ...